MICA: Phenotyping immune responses in asthma and respiratory infections - a systems approach to understanding changes from childhood to adulthood

MICA:哮喘和呼吸道感染的表型免疫反应——一种了解从儿童到成年变化的系统方法

基本信息

  • 批准号:
    MR/L012693/1
  • 负责人:
  • 金额:
    $ 284.82万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2014
  • 资助国家:
    英国
  • 起止时间:
    2014 至 无数据
  • 项目状态:
    已结题

项目摘要

Asthma, allergies and respiratory tract infections (RTIs) are the most common diseases in childhood and adulthood. Although they are inextricably linked, the immune mechanisms governing the relationships between the infection, allergy and increased risk of asthma development and asthma attacks are very poorly understood. Consequently, there have been few advances in treatments for asthma (and in particular asthma attacks) in the last 50 years. Severity and risk of these conditions varies substantially with age, with in particular large changes occurring through puberty - before puberty boys have increased risk/severity of asthma and RTIs, while after puberty females are at substantially greater risk.Impaired immune responses to viruses are strongly implicated in increased susceptibility to virus infections in asthma, but the mechanisms behind these impaired responses are unknown. The mechanisms explaining increased susceptibility to bacterial infections in asthma are unknown.We propose a novel approach aiming to understand the mechanisms of interplay between asthma, allergies and innate immune responses to viruses and bacteria. Building on knowledge we already have of a population of 1000 children, followed since birth to look for risk factors for asthma and allergies, we will collect new data (outlined below) and by using a systems approach to apply innovative computational statistical methods to the data we will study the interactions between host response to infections, allergens and asthma. This will give a better understanding of why children develop asthma, how this changes through puberty and we hope to identify new targets for possible drug therapies. We will combine world-leading expertise in birth cohort/life course studies, respiratory infections, innate immunity, asthma and allergies and computational analysis We will utilise novel analytical techniques to identify mechanisms related to increased susceptibility to RTIs causing increased susceptibility to asthma development and asthma attacksWe will investigate changes in the way the body handles infection from bacteria and viruses from childhood by taking blood cells from the body at age 8 years, through puberty (ages 11 & 14), to adulthood (age 18) and exposing them to these infectious agents and measuring the responseWe will investigate how through puberty the body changes in the way it makes antibodies to allergens, by measuring IgE antibodies at the time points aboveWe will investigate how changes in gene sequences are associated with immunity to infection and to allergens. We will analyse the data using novel computational techniques, recognising that these systems are highly complex and interact with each other, and do not operate in isolationBy studying mechanisms which are important regulators at a molecular level, we will identify potential targets for treatment or prevention of asthma development, asthma attacks and RTIs. Potential therapeutic targets will be validated using molecular cell biology techniques in human primary cells and in vivo studies in which the applicants are well versed.
哮喘、过敏和呼吸道感染(RTIs)是儿童和成年期最常见的疾病。尽管它们之间有着千丝万缕的联系,但控制感染、过敏、哮喘发展和哮喘发作风险增加之间关系的免疫机制却知之甚少。因此,在过去的50年里,哮喘(尤其是哮喘发作)的治疗几乎没有什么进展。这些疾病的严重程度和风险随年龄变化很大,青春期发生的变化尤其大——青春期前,男孩患哮喘和呼吸道感染的风险/严重程度增加,而青春期后,女性患哮喘和呼吸道感染的风险更大。对病毒的免疫反应受损与哮喘患者对病毒感染的易感性增加密切相关,但这些受损反应背后的机制尚不清楚。哮喘患者对细菌感染易感性增加的机制尚不清楚。我们提出了一种新的方法,旨在了解哮喘,过敏和对病毒和细菌的先天免疫反应之间的相互作用机制。基于我们已经拥有的1000名儿童人口的知识,从出生开始寻找哮喘和过敏的危险因素,我们将收集新的数据(如下所述),并通过使用系统方法将创新的计算统计方法应用于数据,我们将研究宿主对感染,过敏原和哮喘的反应之间的相互作用。这将使我们更好地理解儿童患哮喘的原因,以及这种情况在青春期是如何变化的,我们希望找到可能的药物治疗的新目标。我们将结合世界领先的出生队列/生命历程研究、呼吸道感染、先天免疫、我们将利用新的分析技术来确定与RTIs易感性增加相关的机制,从而导致哮喘发展和哮喘发作的易感性增加。我们将通过从8岁到青春期(11岁和14岁)从体内提取血细胞来研究人体处理细菌和病毒感染的方式的变化。到成年期(18岁),让他们接触这些传染性病原体,并测量他们的反应。我们将通过测量上述时间点的IgE抗体,研究青春期身体产生过敏原抗体的方式是如何变化的。我们将研究基因序列的变化是如何与对感染和过敏原的免疫联系起来的。我们将使用新颖的计算技术分析数据,认识到这些系统是高度复杂的,彼此相互作用,并且不是孤立地运行。通过研究分子水平上重要的调节机制,我们将确定治疗或预防哮喘发展,哮喘发作和rti的潜在靶点。潜在的治疗靶点将使用分子细胞生物学技术在人原代细胞和申请人精通的体内研究中进行验证。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Attenuating COVID-19 infection and inflammation: Lessons from asthma.
减轻 COVID-19 感染和炎症:哮喘的教训。
  • DOI:
    10.1111/resp.13961
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Bardin PG
  • 通讯作者:
    Bardin PG
Modeling Wheezing Spells Identifies Phenotypes with Different Outcomes and Genetic Associates.
  • DOI:
    10.1164/rccm.202108-1821oc
  • 发表时间:
    2022-04-15
  • 期刊:
  • 影响因子:
    24.7
  • 作者:
    Haider, Sadia;Granell, Raquel;Curtin, John;Fontanella, Sara;Cucco, Alex;Turner, Stephen;Simpson, Angela;Roberts, Graham;Murray, Clare S.;Holloway, John W.;Devereux, Graham;Cullinan, Paul;Arshad, Syed Hasan;Custovic, Adnan
  • 通讯作者:
    Custovic, Adnan
Machine learning to identify pairwise interactions between specific IgE antibodies and their association with asthma: A cross-sectional analysis within a population-based birth cohort.
  • DOI:
    10.1371/journal.pmed.1002691
  • 发表时间:
    2018-11
  • 期刊:
  • 影响因子:
    15.8
  • 作者:
    Fontanella S;Frainay C;Murray CS;Simpson A;Custovic A
  • 通讯作者:
    Custovic A
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sebastian Johnston其他文献

Soluble mediators derived from bronchial epithelium are able to drive Th2 differentiation in the context of rhinovirus infection
  • DOI:
    10.1186/2045-7022-3-s1-o1
  • 发表时间:
    2013-05-03
  • 期刊:
  • 影响因子:
    4.000
  • 作者:
    Heidi Makrinioti;Ross Walton;Nikolaos Papadopoulos;Michael Edwards;Aurica Telcian;David Cousins;Kerstin Wanke;Luminita Stanciu;Mubeccel Akdis;Spyridon Megremis;Cezmi Akdis;Sebastian Johnston
  • 通讯作者:
    Sebastian Johnston

Sebastian Johnston的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sebastian Johnston', 18)}}的其他基金

MICA: Effect of CRTH2 Antagonist OC459 on Response to Rhinovirus Challenge in Asthma
MICA:CRTH2 拮抗剂 OC459 对哮喘鼻病毒攻击反应的影响
  • 批准号:
    MR/M025330/1
  • 财政年份:
    2015
  • 资助金额:
    $ 284.82万
  • 项目类别:
    Research Grant
MRC-GSK Alliance: Mechanisms of interplay between allergy and viruses in asthma
MRC-GSK 联盟:哮喘中过敏和病毒之间相互作用的机制
  • 批准号:
    G1100238/1
  • 财政年份:
    2012
  • 资助金额:
    $ 284.82万
  • 项目类别:
    Research Grant
MRC-Asthma UK Centre in Allergic Mechanisms of Asthma (2)
MRC-Asthma 英国哮喘过敏机制中心 (2)
  • 批准号:
    G1000758-E01/2
  • 财政年份:
    2011
  • 资助金额:
    $ 284.82万
  • 项目类别:
    Research Grant
MRC-Asthma UK Centre in Allergic Mechanisms of Asthma (2)
MRC-Asthma 英国哮喘过敏机制中心 (2)
  • 批准号:
    G1000758-E01/1
  • 财政年份:
    2011
  • 资助金额:
    $ 284.82万
  • 项目类别:
    Research Grant
Mechanisms of Deficient Innate Immune Responses in Asthma
哮喘先天免疫反应缺陷的机制
  • 批准号:
    G0601236/1
  • 财政年份:
    2008
  • 资助金额:
    $ 284.82万
  • 项目类别:
    Research Grant
Role of Oxidative and Nitrative Stress and Histone De-acetylation in Rhinovirus Induced Acute Exacerbations of COPD
氧化应激、硝基应激以及组蛋白去乙酰化在鼻病毒诱导的慢性阻塞性肺病急性加重中的作用
  • 批准号:
    G0600879/1
  • 财政年份:
    2007
  • 资助金额:
    $ 284.82万
  • 项目类别:
    Research Grant

相似海外基金

Integration of Immunologic Phenotyping with Computational Approaches to Predict Clinical Trajectory in Septic Patients
免疫表型分析与计算方法相结合来预测脓毒症患者的临床轨迹
  • 批准号:
    10708534
  • 财政年份:
    2023
  • 资助金额:
    $ 284.82万
  • 项目类别:
The Intermountain West-Atlantic Center (InterACT) for the APS Phenotyping Consortium
APS 表型联盟的山间西大西洋中心 (InterACT)
  • 批准号:
    10649343
  • 财政年份:
    2023
  • 资助金额:
    $ 284.82万
  • 项目类别:
Sub-phenotyping pneumonia by lung pathobiology
通过肺部病理学对肺炎进行亚表型分析
  • 批准号:
    10749997
  • 财政年份:
    2023
  • 资助金额:
    $ 284.82万
  • 项目类别:
EAP-Derived Monoclonal Antibodies for Phenotyping Immune Cells of Animal Model of Disease
EAP 衍生单克隆抗体用于疾病动物模型免疫细胞表型分析
  • 批准号:
    10933282
  • 财政年份:
    2023
  • 资助金额:
    $ 284.82万
  • 项目类别:
Using implantable microdevices for deep phenotyping of multiple drug responses in brain tumor patients
使用植入式微型设备对脑肿瘤患者的多种药物反应进行深度表型分析
  • 批准号:
    10732396
  • 财政年份:
    2023
  • 资助金额:
    $ 284.82万
  • 项目类别:
Multimodality Deep Phenotyping of Postural Orthostatic Tachycardia Syndrome (POTS)
体位性心动过速综合征 (POTS) 的多模态深度表型分析
  • 批准号:
    10733708
  • 财政年份:
    2023
  • 资助金额:
    $ 284.82万
  • 项目类别:
Spatial transcriptional phenotyping of Sjögren’s disease tissue-resident mesenchymal stromal cells and neighbors in labial salivary glands
干燥病组织驻留间充质基质细胞和唇唾液腺邻近细胞的空间转录表型
  • 批准号:
    10575107
  • 财政年份:
    2023
  • 资助金额:
    $ 284.82万
  • 项目类别:
Deep phenotyping of fusion oncoprotein-driven pediatric cancer metastasis with single-cell proteomics
利用单细胞蛋白质组学对融合癌蛋白驱动的儿科癌症转移进行深度表型分析
  • 批准号:
    10687394
  • 财政年份:
    2023
  • 资助金额:
    $ 284.82万
  • 项目类别:
Phenotyping ARDS, Pneumonia, and Sepsis over time to elucidate shared and distinct trajectories ofillness and recovery
随着时间的推移对 ARDS、肺炎和脓毒症进行表型分析,以阐明共同和不同的疾病和康复轨迹
  • 批准号:
    10649194
  • 财政年份:
    2023
  • 资助金额:
    $ 284.82万
  • 项目类别:
Implementation of Continuum of Care Sepsis Phenotyping and Risk Stratification
脓毒症表型分析和风险分层连续护理的实施
  • 批准号:
    10429829
  • 财政年份:
    2022
  • 资助金额:
    $ 284.82万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了